Ontology highlight
ABSTRACT:
SUBMITTER: Han C
PROVIDER: S-EPMC6014583 | biostudies-literature | 2018 Aug
REPOSITORIES: biostudies-literature
Han Chanhee C Bellone Stefania S Zammataro Luca L Schwartz Peter E PE Santin Alessandro D AD
Gynecologic oncology reports 20180524
<h4>Background</h4>Management of advanced/recurrent low-grade serous ovarian carcinoma (LGOSC) is often challenging. Effective treatment options remain limited for hormone and chemotherapy-resistant LGSOC.CASE: A 65-year-old woman with recurrent widespread LGSOC harboring the KRAS-G12 V hotspot mutation experienced a dramatic clinical response to Binimetinib (MEK162), a mitogen-activated protein kinase (MEK) inhibitor, after failing multiple chemotherapy and hormonal treatments. An 81% reduction ...[more]